Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders have significant skin in the game with 67% ownership

Key Insights Nuvectis Pharma's significant insider ownership suggests inherent interests in company's expansion The top...

Related Keywords

Ron Bentsur ,Nuvectis Pharma ,Charles Mosseri Marlio ,Charles Marlio ,Nuvectis Pharma Inc , ,Insider Ownership ,Dharma ,Shareholders ,Company ,